Suma(B)BabuMDMBBS, MPH(She/Her)

Neurology • Boston, MA

Neuromuscular Medicine, Neurodegenerative

Assistant Professor of Neurology

Join to view full profile

Dr. Babu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Babu's full profile

Already have an account?

Office
55 Fruit Street
Boston, MA 02114

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neurology, 2015 - 2016
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolFellowship, Neuromuscular Medicine (Neurology), 2015 - 2016
Cleveland Clinic FoundationResidency, Neurology, 2013 - 2015
Cleveland Clinic FoundationInternship, Internal Medicine, 2014 - 2014
Cleveland Clinic FoundationFellowship, Child Neurology, 2011 - 2014
Cleveland Clinic FoundationResidency, Pediatrics, 2009 - 2011
University of Maryland School of Public HealthMPH, clinical research, 2006 - 2008
Bangalore Medical CollegeClass of 2003

Certifications & Licensure

MA State Medical License 2015 - 2026
ME State Medical License 2021 - 2026
NH State Medical License 2022 - 2026
OH State Medical License 2009 - 2015
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Publications & Presentations

PubMed

Clinician Perspectives Highlight the Need for Early Dyadic Coping Skills for People Living With Amyotrophic Lateral Sclerosis.
Christina L Rush, Chris Lyons, Jenna Gittle, Morgan Seward, Jennifer Scalia
Journal of Pain and Symptom Management. 2025-03-01
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis.
Alexandra Lovett, Sowmya Chary, Suma Babu, Gaëlle Bruneteau, Jonathan D Glass
Muscle & Nerve. 2025-02-27
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
, Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-02-17

Journal Articles

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine
Integrated Imaging of [11C]-PBR28 PET, MR Diffusion and Magnetic Resonance Spectroscopy 1H-MRS in Amyotrophic Lateral Sclerosis
Sabrina Paganoni, Nazem Atassi, Suma Babu, ScienceDirect

Abstracts/Posters

Capecitabine Induced Multifocal Leukoencephalopathy: A Case report
SBabu, LVelander, JVensel-Rundo, American society for Neuroimaging, Las Vegas, Nevada, 1/2013
Differences in mouth-level nicotine delivery with variation in cigarette smoke pH
SBabu, PClark et al, 9 International Joint Conference of SRNT (Society for Research on Nicotine and Tobacco) S, Dublin, Ireland, 4/2009

Lectures

Statin Induced Necrotizing Autoimmune Myopathy. Podium presentation at the Neurological Institute Grand Rounds, Cleveland.
Cleveland Clinic - 3/2014

Other

Menthol Cigarettes: What do we know?” Background paper presented to the World Health Organization
Clark.P, Babu.S, Sharma.E, WHO
11/1/2008

Press Mentions

Sean M. Healey & AMG Center Announces Topline Results in HEALEY ALS Platform Trial with eIF2B Agonist DNL343January 6th, 2025
Sean M. Healey & AMG Center for ALS Announces First Participant Dosed in Regimen G of the HEALEY ALS Platform Trial Evaluating DNL343 by Denali TherapeuticsJune 8th, 2023

Grant Support

An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with PridopidineMASSACHUSETTS GENERAL HOSPITAL2023–2027
An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with PridopidineMASSACHUSETTS GENERAL HOSPITAL2023–2027
An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with PridopidineMASSACHUSETTS GENERAL HOSPITAL2023–2027
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral SclerosisMASSACHUSETTS GENERAL HOSPITAL2023–2026
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral SclerosisMASSACHUSETTS GENERAL HOSPITAL2023–2026
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral SclerosisMASSACHUSETTS GENERAL HOSPITAL2023–2026
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral SclerosisMASSACHUSETTS GENERAL HOSPITAL2023–2026
Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2025
An Expanded Access Protocol of Intravenous Trehalose Injection 90 mg/mL Treatment of Patients with Amyotrophic Lateral SclerosisMASSACHUSETTS GENERAL HOSPITAL2022–2025